产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
BST2分子别名
Bone marrow stromal antigen 2; BST-2; HM1.24 antigen; CD317; Bst2免疫原
Recombinant Protein细胞定位
Cell membrane, Cytoplasm, EndosomeAccession
Q8R2Q8克隆号
S-2114-32抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Ms阳性样本
RAW264.7, mouse spleen, mouse thymus纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB
稀释度
应用 稀释度 推荐种属 WB 1:1000 Ms
BST2 protein, also known as bone marrow stromal antigen 2 or CD317, is a type of protein that plays significant roles in various biological processes. It is a type II transmembrane protein mainly expressed on the surface of cells such as fibroblasts, endothelial and cells some immune cells. One of its key functions is in the regulation of cell proliferation and differentiation. For example, in the bone marrow microenvironment, BST2 protein can influence the growth and development of hematopoietic cells by interacting with other molecules. Moreover, it is involved in the immune response. It can affect the activation and function of immune cells like T cells and B cells, thus participating in the regulation of the body's immune defense mechanism. Additionally, BST2 protein has been found to be associated with some diseases. Abnormal expression of BST2 protein may be related to the occurrence and development of certain cancers and autoimmune diseases. Therefore, research on BST2 protein is of great importance for understanding the mechanisms of cell biology and disease pathogenesis.
免疫印迹
WB result of BST2 Recombinant Rabbit mAb
Primary antibody: BST2 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: C2C12 whole cell lysate 20 µg
Lane 2: RAW264.7 whole cell lysate 20 µg
Lane 3: mouse spleen lysate 20 µg
Lane 4: mouse thymus lysate 20 µg
Negative control: C2C12 whole cell lysate
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 19 kDa
Observed MW: 28-35, 48-75 kDa
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定







评论(0)